Sanofi, BEYFORTUS
As this year’s respiratory syncytial virus (RSV) season approaches, Beyfortus makers Sanofi and AstraZeneca are making ...
RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...
Two studies published in Pediatrics demonstrate safety and efficacy for the respiratory syncytial virus (RSV) preventive drug ...
October: time for muddy soccer practices, cider pressing and Halloweentown ... And time to roll up your sleeves.
The Nunavut government says it will provide immunization against respiratory syncytial virus to all infants in the territory ...
With a new production line, Sanofi aims to keep it and partner AstraZeneca’s drug Beyfortus in fully supply this RSV season.
The new, free vaccine, Beyfortus, will be available to children up to 24 months old through their health care provider or at ...